CCL3 and experimental autoimmune encephalomyelitis: It has been reported in experimental autoimmune encephalomyelitis that mononuclear cell infiltration in the acute disease and the relapse phase is controlled by CCL3 or CCL2, respectively (Kennedy et al., 1998), suggesting a distinct functional differentiation of both chemokines.